Postoperative Bloodstream Infections in Patients with Peritoneal Surface Malignancies Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Risk Factors and Pathogen Resistance

References

• Yang R, Su YD, Ma R, Li Y. Clinical epidemiology of peritoneal metastases in China: the construction of professional peritoneal metastases treatment centers based on the prevalence rate. Eur J Surg Oncol. 2023;49(1):173–178. PMID: 36064631. doi:10.1016/j.ejso.2022.08.023
   PubMed Web of Science ®Google Scholar
• Smibert OC, Slavin MA, Teh B, et al. Epidemiology and risks for infection following cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. Support Care Cancer. 2020;28(6):2745–2752. PMID: 31712951. doi:10.1007/s00520-019-05093-5
   PubMed Web of Science ®Google Scholar
• Waters PS, Smith AW, Fitzgerald E, et al. Increased incidence of central venous catheter-related infection in patients undergoing cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. Surg Infect. 2019;20(6):465–471. PMID: 31013189. doi:10.1089/sur.2018.250
   PubMed Web of Science ®Google Scholar
• Arslan NC, Sokmen S, Avkan-Oguz V, et al. Infectious complications after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. Surg Infect. 2017;18(2):157–163. PMID: 27906610. doi:10.1089/sur.2016.102
   PubMed Web of Science ®Google Scholar
• Anwar A, Kasi A. Peritoneal Cancer. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024.
   Google Scholar
• Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21(20):3737–3743. PMID: 14551293. doi:10.1200/JCO.2003.04.187
   PubMed Web of Science ®Google Scholar
• Yang XJ, Huang CQ, Suo T, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a Phase III randomized clinical trial. Ann Surg Oncol. 2011;18(6):1575–1581. PMID: 21431408; PMCID: PMC3087875. doi:10.1245/s10434-011-1631-5
   PubMed Web of Science ®Google Scholar
• Spiliotis J, Halkia E, Lianos E, et al. Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study. Ann Surg Oncol. 2015;22(5):1570–1575. PMID: 25391263. doi:10.1245/s10434-014-4157-9
   PubMed Web of Science ®Google Scholar
• van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378(3):230–240. PMID: 29342393. doi:10.1056/NEJMoa1708618
   PubMed Web of Science ®Google Scholar
• Paredes AZ, Abdel-Misih S, Schmidt C, Dillhoff ME, Pawlik TM, Cloyd JM. Predictors of readmission after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Res. 2019;234:103–109. PMID: 30527460. doi:10.1016/j.jss.2018.09.022
   PubMed Web of Science ®Google Scholar
• Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359–374. PMID: 8849962. doi:10.1007/978-1-4613-1247-5_23
   PubMedGoogle Scholar
• Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221(1):29–42. PMID: 7826158; PMCID: PMC1234492. doi:10.1097/00000658-199501000-00004
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. Cytoreductive surgery and perioperative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol. 2001;27(3):239–243. PMID: 11373099. doi:10.1053/ejso.2000.1038
   PubMed Web of Science ®Google Scholar
• Bastug A, Kayaaslan B, Kazancioglu S, et al. Emergence of multidrug resistant isolates and mortality predictors in patients with solid tumors or hematological malignancies. J Infect Dev Ctries. 2015;9(10):1100–1107. PMID: 26517485. doi:10.3855/jidc.6805
   PubMed Web of Science ®Google Scholar
• Zhang GY, Wu YD, Xie SF, et al. Distribution and antimicrobial resistance of pathogens causing bloodstream infection in patients with hematological diseases in 2012–2016. Chin J Infect Control. 2018;17(10):853–859.
   Google Scholar
• Zhang BR, Lliu GY, Wen Y, et al. Distribution and drug resistance analysis of pathogenic bacteria detected in blood culture. J Nanjing Med Univ. 2015;35(6):878–883.
   Google Scholar
• Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546–1554. PMID: 12700374. doi:10.1056/NEJMoa022139
   PubMed Web of Science ®Google Scholar
• De Francesco MA, Ravizzola G, Peroni L, Bonfanti C, Manca N. Prevalence of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in an Italian hospital. J Infect Public Health. 2013;6(3):179–185. PMID: 23668462. doi:10.1016/j.jiph.2012.11.006
   PubMed Web of Science ®Google Scholar
• Li GH, Zhu DM, Wang F, et al. Distribution and drug resistance of clinical isolates of CHINET blood culture in China in 2011. Chin J Infect Chemother. 2013;13(04):241–247. doi:10.16718/j.1009-7708.2013.04.002
   Google Scholar
• Ma XZ, Lv Y, Zheng B. Monitoring of bacterial resistance of bloodstream infections in 2011 in the national bacterial resistance monitoring network of the ministry of health. Chin J Clin Pharmacol. 2012;28(12):927–932. doi:10.13699/j.cnki.1001-6821.2012.12.009
   Google Scholar
• Zhang H, Yang QW, Xu YC, Xie XL. Distribution and drug resistance of pathogenic bacteria in blood culture in Peking Union Medical College Hospital from 2000 to 2013. Lab Med Clin. 2014;11(18):2499–2502.
   Google Scholar
• Al Thaqafi AH, Farahat FM, Al Harbi MI, Al Amri AF, Perfect JR. Predictors and outcomes of Candida bloodstream infection: eight-year surveillance, western Saudi Arabia. Int J Infect Dis. 2014;21:5–9. PMID: 24468816. doi:10.1016/j.ijid.2013.12.012
   PubMed Web of Science ®Google Scholar
• Yao WY, Zeng J, Xue YX, Wang D. Research progress of antimicrobial resistance and novel antimicrobial therapy. Chin J Antibiot. 2017;42(05):321–327. doi:10.13461/j.cnki.cja.005877
   Google Scholar
• Papanicolas LE, Gordon DL, Wesselingh SL, Rogers GB. Not just antibiotics: is cancer chemotherapy driving antimicrobial resistance? Trends Microbiol. 2018;26(5):393–400. Epub 2017 Nov 13. PMID: 29146383. doi:10.1016/j.tim.2017.10.009
   PubMed Web of Science ®Google Scholar